Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Yongchang Zhang's publication output changed over time?
ScholarIQpublication output · 2020–2025
Output declined80% over the shown period — from 5 works in 2020 to 1 in 2025.
5
4
1
1
2020202120222025
What are the most-cited papers on Yongchang Zhang?
ScholarIQmost cited works
ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis
Hong Liu, Xinwei Kuang, Yongchang Zhang, Youqiong Ye, Jialu Li, Long Liang, Zuozhong Xie, Liang Weng, Jia Guo, Hui Li, Fangyu Ma, Xiaodan Chen, Xiaodan Chen, Shuang Zhao, Juan Su, Fang Fang, Fang Fang, Yang Xie, Juan Tao, Jianglin Zhang, Mingliang Chen, Cong Peng, Lun‐Quan Sun, Xin Zhang, Jing Liu, Leng Han, Xiaowei Xu, Mien‐Chie Hung, Xiang Chen, Xiang Chen
S25671836. 2020260 CitationsOPEN ACCESS
Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1
Youqiong Ye, Xinwei Kuang, Zuozhong Xie, Long Liang, Zhao Zhang, Yongchang Zhang, Fangyu Ma, Qian Gao, Ruimin Chang, Heng‐Huan Lee, Shuang Zhao, Juan Su, Hui Li, Jingbo Peng, Huifang Chen, Minzhu Yin, Cong Peng, Nong Yang, Jing Wang, Jing Liu, Hong Liu, Leng Han, Xiang Chen
S149201819. 2020158 CitationsOPEN ACCESS
Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy
Ying Jing, Yongchang Zhang, Jing Wang, Kunyan Li, Xue Chen, Xue Chen, Jianfu Heng, Qian Gao, Youqiong Ye, Zhao Zhang, Yaoming Liu, Yanyan Lou, Steven H. Lin, Lixia Diao, Hong Liu, Xiang Chen, Xiang Chen, Gordon B. Mills, Leng Han
JNCI Journal of the National Cancer Institute. 2021107 Citations
Effective Treatment of Lung Adenocarcinoma Harboring EGFR-Activating Mutation, T790M, and cis-C797S Triple Mutations by Brigatinib and Cetuximab Combination Therapy
Yubo Wang, Nong Yang, Yongchang Zhang, Li Li, Rui Han, Mengxiao Zhu, Mingxia Feng, Hengyi Chen, Analyn Lizaso, Qin Tian, Xiaoyan Liu, Yong He
Journal of Thoracic Oncology. 2020103 Citations
Spatial immune scoring system predicts hepatocellular carcinoma recurrence
Gengjie Jia, Peiqi He, Tianli Dai, Denise Goh, Jiabei Wang, Mengyuan Sun, Felicia Wee, Fuling Li, Jeffrey Chun Tatt Lim, Shuxia Hao, Yao Liu, Tony Kiat Hon Lim, Nye Thane Ngo, Qingping Tao, Wei Wang, Ahitsham Umar, Björn Nashan, Yongchang Zhang, Chen Ding, Joe Yeong, Lianxin Liu, Cheng Sun
Nature. 202587 Citations
Related on ScholarIQ
Qinghai University
Institution
ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis
Paper
Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1
Paper
Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy
Paper
Effective Treatment of Lung Adenocarcinoma Harboring EGFR-Activating Mutation, T790M, and cis-C797S Triple Mutations by Brigatinib and Cetuximab Combination Therapy
Paper
Spatial immune scoring system predicts hepatocellular carcinoma recurrence
Paper